Evidence map›Paper›PMID 28468855›Full record

ArticleJournal of clinical microbiology2017

Simple Screening for Carbapenemase-Producing Enterobacteriaceae by Moxalactam Susceptibility Testing.

Waka Imai, Masakazu Sasaki, Kotaro Aoki, Yoshikazu Ishii, Robert A Bonomo, Tse Hsien Koh, Hinako Murakami, Toshisuke Morita, Kazuhiro Tateda

Abstract readLetter
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Evaluation of the VITEK2 AST-XN17 card for the detection of carbapenemase-producing Enterobacterales in isolates primarily producing metallo β-lactamase.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Waka ImaiDepartment of Clinical Laboratories, Toho University Omori Medical Centre, Tokyo, Japan.
Masakazu SasakiDepartment of Clinical Laboratories, Toho University Omori Medical Centre, Tokyo, Japan.
Kotaro AokiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan.
Yoshikazu IshiiDepartment of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan yishii@med.toho-u.ac.jp.
Robert A BonomoDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio, USA.
Tse Hsien KohDepartment of Microbiology, Singapore General Hospital, Singapore.
Hinako MurakamiDepartment of Clinical Laboratories, Toho University Omori Medical Centre, Tokyo, Japan.
Toshisuke MoritaDepartment of Clinical Laboratories, Toho University Omori Medical Centre, Tokyo, Japan.
Kazuhiro TatedaDepartment of Clinical Laboratories, Toho University Omori Medical Centre, Tokyo, Japan.

Funding

Understanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6M
Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
A Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4M
Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniaeR21AI114508 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., VAN DUIN, DAVID · 2015 to 2016
$445k
The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1I01BX001974 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BONOMO, ROBERT A. · 2013 to 2024
–
BLRD VA I01 BX001974NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01 AI100560NIAID NIH HHS R21 AI114508
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeHumansMicrobial Sensitivity TestsMoxalactamAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseMoxalactamcarbapenemase-producing Enterobacteriaceaedetectionmoxalactamscreening

Identifiers

PMID28468855
PMCPMC5483931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.